11-Jul-17 Total health care spending in Asia today stands at about USD1.3 tn. By 2030, that's going to grow to about USD4.3 tn, growing at about 15 percent per annum," says private equity firm Quadria Capital. [image: BSIP / UIG / Getty Images / CNBC]

23-May-17 DKSH, the biggest player in the Myanmar healthcare market, and the pharmaceutical company Boehringer Ingelheim have signed an agreement to provide Myanmar patients better treatment options in vascular disease, arterial hypertension, cancer and diabetes. [image: DKSH]

27-Feb-17 With an economic potential still largely untapped, the Greater Mekong Region should be front and center in the plans of any pharma, medical device or biotech organization looking to expand in Asia. Among the volatile and unpredictable emerging markets throughout Asia, Vietnam and Myanmar have shown strong growth in their economies and appetite for pharma and medical devices. [image: Life Science Leader]

23-Jan-17 The influx of NGOs in Cambodia may have weakened the government health sector. A report has found that Cambodia has been more dependent on health NGOs than other case studies. While “international aid was critical to support the country’s reconstruction”, the study also claims that conflicting agendas “did not help strengthening government stewardship and ownership of health sector development”. [image: Tang Chhin Sothy / AFP]

08-Dec-16 As competition heats up in Singapore between private and public healthcare providers, many are looking at regional expansion for growth opportunities. Across the hospital players in the region, consensus is looking towards emerging markets like Cambodia and Vietnam for expansion. [image: Company, OIR]